Attached files
Exhibit 32.1
CERTIFICATION
OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT
TO 18 U.S. C. SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report on Form 10-K of Cantabio
Pharmaceuticals Inc. (the “Company”) for the fiscal
year ended March 31, 2018, as filed with the Securities and
Exchange Commission on the date hereof (the “Report”),
I, Gergely Toth, Principal Executive Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that, to my
knowledge:
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
|
|
(2)
|
The information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
|
Dated: July 13,
2018
|
/s/ Gergely Toth
|
Gergely Toth
|
Principal Executive Officer
|